![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 263/57 | (2006.01) |
A61K 31/423 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 3191461 |
(13) | Kind of document | T |
(96) | European patent application number | 15771276.1 |
Date of filing the European patent application | 2015-08-31 | |
(97) | Date of publication of the European application | 2017-07-19 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
(46) | Date of publication of the claims translation | 2021-12-10 |
(86) | Number | PCT/IB2015/056597 |
Date | 2015-08-31 |
(87) | Number | WO 2016/038500 |
Date | 2016-03-17 |
(30) | Number | Date | Country code |
201462047614 P | 2014-09-08 | US | |
201562203953 P | 2015-08-12 | US |
(72) |
GIRARD, Kevin Paul , US
JENSEN, Andrew J. , US
JONES, Kris Nicole , US
|
(73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 6-Karboksi-2-(3,5-dichlorfenil)-benzoksazolo kristalinės kietos formos |
CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE |
Payment date | Validity (years) | Amount | |
2025-07-10 | 11 | 289.00 EUR |
2026-08-31 |